Line 1,812: |
Line 1,812: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:EBV-positive diffuse large B-cell lymphoma|EBV-positive diffuse large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | + | |[[HAEM5:EBV-positive diffuse large B-cell lymphoma|EBV-positive diffuse large B-cell lymphoma]]||Disease||Fnu Monika (trainee) + Andrew Siref as mentor |
| + | |3/22/24|| ||Pending|| ||GC|| || |
| |NEW (No Prior) | | |NEW (No Prior) |
| |NEW (No Prior) | | |NEW (No Prior) |
Line 2,325: |
Line 2,326: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD | + | |[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD |
| |3/20/24 | | |3/20/24 |
− | | || || ||SK|| || | + | | ||Pending|| ||SK|| || |
| |Enteropathy-Associated T-cell Lymphoma | | |Enteropathy-Associated T-cell Lymphoma |
| |*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | | |*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD |
Line 2,334: |
Line 2,335: |
| | | | | |
| |- | | |- |
− | |[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD | + | |[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD |
| |3/20/24 | | |3/20/24 |
− | | || || ||SK|| || | + | | ||Pending|| ||SK|| || |
| |Monomorphic Epitheliotropic Intestinal T-cell Lymphoma | | |Monomorphic Epitheliotropic Intestinal T-cell Lymphoma |
| |Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | | |Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD |
Line 2,426: |
Line 2,427: |
| |NEW (No Prior) | | |NEW (No Prior) |
| |- | | |- |
− | |[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease|| || || || || ||SK|| || | + | |[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Monika Fnu (trainee), Andrew Siref, MD||3/22/24|| ||Pending|| ||SK|| || |
| |NEW (No Prior) | | |NEW (No Prior) |
| |NEW (No Prior) | | |NEW (No Prior) |